Trials / Conditions / ARID1A Gene Mutation
ARID1A Gene Mutation
5 registered clinical trials studyying ARID1A Gene Mutation — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Avelumab and M1774 in ARID1A-mutated Endometrial Cancer NCT06518564 | Panagiotis Konstantinopoulos, MD, PhD | Phase 2 |
| Terminated | Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation NCT05523440 | University of Oklahoma | Phase 2 |
| Recruiting | JAB-2485 Activity in Adult Patients With Advanced Solid Tumors NCT05490472 | Jacobio Pharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation NCT05023655 | Prisma Health-Upstate | Phase 2 |
| Active Not Recruiting | A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Ca NCT05226507 | Nuvectis Pharma, Inc. | Phase 1 |